InstaDeep's chief executive, speaking as part of BioNTech's AI Day, said a key focus is the DeepChain multiomics design platform. He said DeepChain is now open for external partnerships after successful application to several projects, including the mRNA-encoded antibody RiboMab platform.
Source
Company Archive pending